Medications for Venous Thromboembolism
4 results
Eliquis (apixaban)
(apixaban)E.R. Squibb & Sons, L.L.C.
Usage: ELIQUIS is indicated for reducing stroke risk in nonvalvular atrial fibrillation, preventing deep vein thrombosis after hip or knee surgery, and treating deep vein thrombosis and pulmonary embolism. It also helps reduce the risk of recurrence of DVT and PE, and treats venous thromboembolism in pediatric patients after initial therapy.
Fragmin (dalteparin sodium)
(Dalteparin Sodium)Pfizer Laboratories Div Pfizer Inc
Usage: FRAGMIN is indicated for the prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction, deep vein thrombosis (DVT) prevention in surgical and at-risk patients, extended treatment of symptomatic VTE in cancer patients, and VTE treatment in pediatric patients. It is not for acute VTE treatment.
Xarelto (rivaroxaban)
(rivaroxaban)Cardinal Health 107, LLC
Usage: XARELTO is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), preventing DVT post-surgery, and pediatric thromboprophylaxis. It also reduces major cardiovascular events in coronary artery disease and thrombotic events in peripheral artery disease patients.
Xarelto (rivaroxaban)
(rivaroxaban)Janssen Pharmaceuticals, Inc.
Usage: XARELTO is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing recurrence of these conditions. It also provides prophylaxis for DVT after surgery and reduces cardiovascular and thrombotic event risks in specific patient populations.